Stay updated on Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.

Latest updates to the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page
- ChecktodayChange DetectedRemoved a government funding operating status notice. The study details and contacts on the page remain unchanged; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe new screenshot shows layout and styling changes without changes to the trial's core details such as eligibility, locations, or enrollment.SummaryDifference0.4%

- Check43 days agoChange DetectedMajor update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.SummaryDifference5%

- Check50 days agoChange DetectedPage now shows revision to v3.1.0 and removes several drug-safety-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a shift away from those topics while adding a new version.SummaryDifference0.6%

- Check65 days agoChange DetectedRelease updated from v3.0.1 to v3.0.2. The Back to Top element has been removed.SummaryDifference0.3%

- Check72 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.3%

Stay in the know with updates to Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.